You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD85d

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Indolent B-Cell Non-Hodgkin Lymphoma Trial in Worldwide (BI1206)

Recruiting
  • Indolent B-Cell Non-Hodgkin Lymphoma
  • BI1206
  • Atlanta, Georgia
  • +8 more
Mar 1, 2022

Hepatolenticular Degeneration; Wilson Trial in Bron, Lyon, Barcelona (Low-volume continuous veno-venous haemodialysis)

Recruiting
  • Hepatolenticular Degeneration; Wilson
  • Low-volume continuous veno-venous haemodialysis
  • Bron, Rhône-Alpes, France
  • +3 more
Jun 27, 2023

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Lymphoma Trial in Houston (PCV20)

Not yet recruiting
  • Lymphoma
  • PCV20
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2023

Interleukins in Periodontal Disease Progression

Recruiting
  • Periodontitis
  • Gingivitis
  • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
  • Assiut, Asyut, Egypt
    Department of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023

Mild Intellectual Disability, Borderline Intellectual Functioning Trial in San Francisco (D-kit/EF1, Sham group program)

Not yet recruiting
  • Mild Intellectual Disability
  • Borderline Intellectual Functioning
  • D-kit/EF1
  • Sham group program
  • San Francisco, California
    UCSF Nancy Friend Pritzker Psychiatry Building
Jun 27, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

ANCA Associated Vasculitis Trial in Bordeaux (blood sample, urine sample)

Recruiting
  • ANCA Associated Vasculitis
  • blood sample
  • urine sample
  • Bordeaux, France
    CHU de Bordeaux - Service d'Immunologie et Immunogénétique
Dec 13, 2022

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

Not yet recruiting
  • Lymphomas
  • B-cell Lymphomas
  • Houston, Texas
    The University of Texas M D Anderson Cancer Center
Mar 6, 2023

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Biospecimen Collection
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)

Not yet recruiting
  • Hematological Malignancy
  • Fludarabine Phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)

Recruiting
  • Hepatoblastoma
  • Sodium Thiosulfate Injection
  • +10 more
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +15 more
  • Anti-CD19/CD20/CD22 CAR T-Cells
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 4, 2022

High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

Completed
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Daratumumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Late Toxicities After Radiotherapy in Breast and Prostate Cancer

Completed
  • Breast Cancer
  • Prostate Cancer
    • Montpellier, France
      CRLC Val d'Aurelle
    Nov 29, 2022

    Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

    Active, not recruiting
    • Multiple Myeloma
    • Elranatamab (PF-06863135)
    • Beverly Hills, California
    • +75 more
    Oct 4, 2022

    Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

    Not yet recruiting
    • Solid Tumor, Adult
    • HB0045 Drug Product
    • Boston, Massachusetts
    • +2 more
    Jul 5, 2023

    Relapsed or Refractory Multiple Myeloma Trial in Tianjin (QLS32015)

    Recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jun 24, 2023

    Lymphoma, B-Cell Trial in Xi'an (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

    Terminated
    • Lymphoma, B-Cell
    • Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy
    • Xi'an, Shaanxi, China
      Second Affiliated Hospital of Xi'an Jiaotong University
    Oct 28, 2021

    Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

    Active, not recruiting
    • Multiple Myeloma
    • +4 more
    • Total Body Irradiation
    • +5 more
    • Los Angeles, California
      Cedars Sinai Medical Center
    Dec 21, 2022

    Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

    Active, not recruiting
    • Bladder Urothelial Carcinoma
    • +4 more
    • Biopsy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022